Top Markets
#1 Bedrock Bedrock +42.72%
#2 Naoris Protocol Naoris Protocol +24.89%
#3 pippin pippin +18.20%
#4 IQ IQ +17.47%
#5 Bitway Bitway +17.00%
#6 Irys Irys +15.43%
#7 Resolv RLP Resolv RLP +10.78%
#8 Chrema Coin Chrema Coin +10.28%
#9 peaq peaq +9.87%
#10 Green Green +8.39%
Coin of the day
Bedrock Bedrock
Settings
Language
ENGLISH
Currency
USD
Theme
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Rank in Stocks #20441
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Share Price
$0.16328419
Market Cap
$204.14K
Change (1 day)
4.35%
Change (1 year)
102.45%
Country
GB
Trade Fusion Antibodies plc (FAB)

Category

Healthcare
Dividend history for Fusion Antibodies plc (FAB)
Fusion Antibodies plc (stock symbol: FAB) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for Fusion Antibodies plc (FAB) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
52.00%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
5.00%
US
UCB SA UCB SA
UCB SA
UCB.BR
29.00%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL